Magnesium and Vaniqa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Magnesium (magnesium) and Vaniqa (eflornithine hydrochloride). Common drug interactions include death among females.
The phase IV clinical study analyzes what interactions people have when they take Magnesium and Vaniqa. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Magnesium?
Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 121,144 Magnesium users. Check the latest studies of Magnesium.
What is Vaniqa?
Vaniqa has active ingredients of eflornithine hydrochloride. eHealthMe is studying from 639 Vaniqa users. Check the latest studies of Vaniqa.
12 people who take Magnesium and Vaniqa together, and have interactions are studied.
What are the common drug interactions of Magnesium and Vaniqa, by gender? *:
female:
- Death
- Diarrhoea
- Contusion (a type of hematoma of tissue in which capillaries)
- Drug ineffective
- Dyspnoea (difficult or laboured respiration)
- Fall
- Hypoxia (low oxygen in tissues)
- Ingrowing nail
- Mitral valve prolapse (heart's mitral valve doesn't work well)
- Mobility decreased (ability to move is reduced)
male:
n/a
What are the common drug interactions of Magnesium and Vaniqa, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Chronic kidney disease
50-59:
- Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
- Renal failure (kidney dysfunction)
- Septic shock (shock due to blood infection)
60+:
- Death
- Diarrhoea
- Abdominal discomfort
- Alopecia (absence of hair from areas of the body)
- Drug ineffective
What are the existing conditions these people have? *
- Hair Growth Abnormal: 4 people, 33.33%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 25.00%
- Type 2 Diabetes: 3 people, 25.00%
- Stress And Anxiety: 3 people, 25.00%
- Hair Loss: 2 people, 16.67%
- Fever: 2 people, 16.67%
- Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 16.67%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 16.67%
- Fungal Infection: 2 people, 16.67%
- Gastric Ulcer (stomach ulcer): 2 people, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take Magnesium and Vaniqa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Magnesium and Vaniqa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Magnesium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vaniqa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Magnesium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vaniqa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on magnesium and eflornithine hydrochloride (the active ingredients of Magnesium and Vaniqa, respectively), and Magnesium and Vaniqa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Compazine cause Systemic Lupus Erythematosus? - a second ago
- Fenofibric Acid vs. Mevacor, side effect and effectiveness comparison - 21 seconds ago
- Could Camzyos cause Weight Decreased? - 23 seconds ago
- Drug interactions of Adalat and Potassium Aspartate - 30 seconds ago
- Drug interactions of Detrol La and Clonazepam - 35 seconds ago
- Could Sodium Chloride 0.9% cause Abdominal Pain? - 43 seconds ago
- Could Coq cause Diplopia? - a minute ago
- Could Strattera cause Gamma-Glutamyltransferase Increased? - a minute ago
- Could Maxzide cause Photosensitivity Reaction? - a minute ago
- Could Aloe cause Joint Pain? - a minute ago